Foghorn Therapeutics (FHTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Foghorn Therapeutics (FHTX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Foghorn Therapeutics

· FHTX

Dashboard

Financials

Ratios

Valuation

Statistics

209.036 M

-18.21%

General

Market Cap: $209.04M
Enterprise Value: $146.47M
Shares Outstanding: 58,710,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 42.73%
Operating Margin: -186.38%
Net Profit Margin: -175.78%
FCF Margin: -232.31%
ROA: -31.75%
ROE: 72.64%
ROIC: -44.00%
Current Ratio: 3.36
Debt-to-Equity: -0.53
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 4.67
P/FCF: —
P/B: —
EV/EBITDA: -2.34

Growth

Rev 1Y: 36.75%
Rev 1Y Fwd Est: 9.74%
Rev 3Y (CAGR): 17.14%
Rev 5Y (CAGR): 135.14%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $36.74M
Gross Margin: 42.73%
Operating Expenses: $84.17M
Operating Income: -$68.48M
Net Profit: -$64.58M

Balance Sheet

Cash and Equivalents: $68.08M
Working Capital: $119.47M
Total Assets: $203.39M
Net Debt: -$24.98M
Total Liabilities: $284.43M
Total Equity: -$81.04M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$85.3M
Cash Flow from Investing: $28.12M
Cash Flow from Financing: $608K
Free Cash Flow: -$85.35M
Capital Expenditures: $50K